Over-expression of lnc-RAB11B-AS1 accelerated the death of osteosarcoma cells, while reduction of lnc-RAB11B-AS1 resulted in resistance of the cells to cisplatin (Figure 7A and Supplementary Figure 4A). Here, RAB11B is linked to osteosarcoma.